China Health Industries Holdings, Inc. engages in the production, marketing, and distribution of medicines, health products, health devices, and cosmetics. The company is headquartered in Harbin, Heilongjiang and currently employs 32 full-time employees. The company went IPO on 2004-12-01. The firm's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The firm owns a GMP-certified plant and production facilities and has the capacity to produce 21 different NMPA-approved medicines, 14 NMPA-approved health supplement products and 8 hemp derivative products in soft capsule, hard capsule, tablet, granule, oral liquid forms. These products address the needs of some key sectors in China, including the feminine, geriatric, and children’s markets.
Follow-Up Questions
China Health Industries Holdings Inc 的 CEO 是谁？
Mr. Xin Sun 是 China Health Industries Holdings Inc 的 Chairman of the Board，自 2007 加入公司。
CHHE 股票的价格表现如何？
CHHE 的当前价格为 $0，在上个交易日 decreased 了 0%。
China Health Industries Holdings Inc 的主要业务主题或行业是什么？
China Health Industries Holdings Inc 属于 Consumer products 行业，该板块是 Consumer Staples
